Global Pneumonia Vaccine Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Vaccine Type;
Pneumococcal Conjugate Vaccine (PCV) and Pneumococcal Polysaccharide Vaccine (PPSV/PPV).Segmented by Product Type;
Prevnar 13, Synflorix, Pneumovax23 and Pipeline Products.Segmented by Sector;
Public Sector and Private Sector.Segmented by Distribution Channel;
Distribution Partner Companies, Non-Governmental Organizations (NGO) and Government Authorities.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Pneumonia Vaccine Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 104.9 |
2021 | 105.8 |
2022 | 117.6 |
2023 | 117.7 |
2024 | 126.4 |
2025 | 144.4 |
2026 | 172.8 |
2027 | 199.6 |
2028 | 216.0 |
2029 | 235.0 |
2030 | 246.0 |
In the year 2023, the Global Pneumonia Vaccine Market was valued at USD 9,707.09 million. The size of this market is expected to increase to USD 14,663.48 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.
Global Pneumonia Vaccine Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Pneumonia Vaccine Market |
Study Period | 2020 - 2030 |
Base Year (for Pneumonia Vaccine Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Pneumonia Vaccine Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Pneumonia Vaccine Market Analysis
In this report, the Global Pneumonia Vaccine Market has been segmented by Vaccine Type, Product Type, Sector, Distribution Channel and Geography. Vaccines against Streptococcus pneumoniae are known as pneumococcal vaccines. Some cases of pneumonia, meningitis, and sepsis can be avoided by using them. Pneumococcal vaccines are classified into two types: conjugate vaccines and polysaccharide vaccines. If you are 65 or older and getting your first pneumococcal vaccine, you will need two shots, one year apart. If you've only had one pneumococcal vaccine in your life, you may now require another. If you received the pneumococcal vaccine before the age of 65, you may now require one or two booster shots.
Global Pneumonia Vaccine Market, Segmentation by Vaccine Type
The Global Pneumonia Vaccine Market has been segmented by Vaccine Type into Pneumococcal Conjugate Vaccine (PCV) and Pneumococcal Polysaccharide Vaccine (PPSV/PPV). The complete Global Pneumonia Vaccine Market segmentation by Vaccine Type can be seen below:
- Global Pneumonia Vaccine Market, By Vaccine Type
- Pneumococcal Conjugate Vaccine (PCV)
- Pneumococcal Polysaccharide Vaccine (PPSV/PPV)
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Vaccine Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Vaccine Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Pneumonia Vaccine Market, by Vaccine Type (USD Million), 2020 - 2030
# | Pneumococcal Conjugate Vaccine (PCV) | Pneumococcal Polysaccharide Vaccine (PPSV/PPV) |
---|---|---|
2020 | 97.4 | 95.5 |
2021 | 97.5 | 101.8 |
2022 | 104.0 | 103.1 |
2023 | 116.4 | 107.7 |
2024 | 122.6 | 128.4 |
2025 | 132.5 | 138.2 |
2026 | 145.9 | 146.7 |
2027 | 159.1 | 166.5 |
2028 | 189.6 | 181.9 |
2029 | 190.5 | 213.6 |
2030 | 202.5 | 220.5 |
Global Pneumonia Vaccine Market, Segmentation by Product Type
The Global Pneumonia Vaccine Market has been segmented by Product Type into Prevnar 13, Synflorix, Pneumovax23 and Pipeline Products. The complete Global Pneumonia Vaccine Market segmentation by Product Type can be seen below:
- Global Pneumonia Vaccine Market, By Product Type
- Prevnar 13
- Synflorix
- Pneumovax23
- Pipeline Products
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Product Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Pneumonia Vaccine Market, by Product Type (USD Million), 2020 - 2030
# | Prevnar 13 | Synflorix | Pneumovax23 | Pipeline Products |
---|---|---|---|---|
2020 | 69.2 | 96.7 | 88.8 | 99.1 |
2021 | 74.0 | 109.8 | 91.5 | 118.5 |
2022 | 79.3 | 116.4 | 91.7 | 125.9 |
2023 | 83.6 | 119.6 | 95.4 | 139.0 |
2024 | 91.6 | 138.4 | 101.5 | 144.6 |
2025 | 102.1 | 163.8 | 105.3 | 167.8 |
2026 | 115.4 | 171.4 | 106.8 | 183.2 |
2027 | 136.9 | 197.6 | 123.2 | 205.3 |
2028 | 149.4 | 213.1 | 123.3 | 224.0 |
2029 | 177.1 | 242.4 | 131.7 | 254.4 |
2030 | 207.7 | 265.5 | 141.1 | 270.1 |
Global Pneumonia Vaccine Market, Segmentation by Sector
The Global Pneumonia Vaccine Market has been segmented by Sector into Public Sector and Private Sector. The complete Global Pneumonia Vaccine Market segmentation by Sector can be seen below:
- Global Pneumonia Vaccine Market, By Sector
- Public Sector
- Private Sector
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Sectors mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Sector is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Pneumonia Vaccine Market, by Sector (USD Million), 2020 - 2030
# | Public Sector | Private Sector |
---|---|---|
2020 | 118.1 | 100.1 |
2021 | 128.3 | 112.6 |
2022 | 145.4 | 130.0 |
2023 | 157.5 | 139.2 |
2024 | 170.3 | 139.5 |
2025 | 197.5 | 152.8 |
2026 | 227.9 | 160.2 |
2027 | 244.5 | 175.6 |
2028 | 283.2 | 199.6 |
2029 | 329.4 | 232.9 |
2030 | 356.7 | 254.8 |
Global Pneumonia Vaccine Market, Segmentation by Distribution Channel
The Global Pneumonia Vaccine Market has been segmented by Distribution Channel into Distribution Partner Companies, Non-Governmental Organizations (NGO) and Government Authorities. The complete Global Pneumonia Vaccine Market segmentation by Distribution Channel can be seen below:
- Global Pneumonia Vaccine Market, By Distribution Channel
- Distribution Partner Companies
- Non-Governmental Organizations (NGO)
- Government Authorities
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Distribution Channels mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Distribution Channel is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Pneumonia Vaccine Market, by Distribution Channel (USD Million), 2020 - 2030
# | Distribution Partner Companies | Non-Governmental Organizations (NGO) | Government Authorities |
---|---|---|---|
2020 | 74.9 | 77.6 | 88.2 |
2021 | 79.4 | 79.2 | 103.7 |
2022 | 82.4 | 84.6 | 107.0 |
2023 | 85.6 | 89.2 | 123.4 |
2024 | 102.5 | 98.2 | 131.6 |
2025 | 116.2 | 105.4 | 138.2 |
2026 | 127.6 | 118.7 | 140.1 |
2027 | 129.3 | 119.9 | 146.8 |
2028 | 138.4 | 129.4 | 147.1 |
2029 | 161.1 | 140.3 | 172.1 |
2030 | 176.7 | 152.7 | 173.0 |
Global Pneumonia Vaccine Market, Segmentation by Geography
In this report, the Global Pneumonia Vaccine Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Pneumonia Vaccine Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Pneumonia Vaccine Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Pneumonia Vaccine in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Pneumonia Vaccine Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Pneumonia Vaccine Market is driven by; Surge in prevalence of pneumonia across the globe, Rise in government focus on immunization programs for pneumonia and Increase in focus for novel pneumococcal vaccines.
- While the growth of Global Pneumonia Vaccine Market is currently hindered by; Longer timelines required for pneumonia vaccine production and High cost associated with development of such vaccines.
- Global Pneumonia Vaccine Market has good growth potential in the future due to the new market opportunities that are being created. The opportunities in this market include; Development of protein-based combination pneumococcal vaccines.
- Surge in prevalence of pneumonia across the globe.
- Rise in government focus on immunization programs for pneumonia.
- Increase in focus for novel pneumococcal vaccines.
- Longer timelines required for pneumonia vaccine production.
- High cost associated with development of such vaccines.
- Development of protein-based combination pneumococcal vaccines.
Market Opportunity Map
This report provides market opportunity map for Pneumonia Vaccine Market. The opportunity map (by market segments; Vaccine Type, Product Type, Sector and Distribution Channel) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Pneumonia Vaccine Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Pneumonia Vaccine Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Pneumonia Vaccine Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Pneumonia Vaccine Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Pneumonia Vaccine Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Pneumonia Vaccine Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Pneumonia Vaccine Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Pneumonia Vaccine Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Pneumonia Vaccine Market include, Glaxosmithkline Plc., Lg Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute Of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., Sk Bioscience and Walvax Biotechnology Co.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Product Type
- Market Snapshot, By Sector
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Opportunity Map
- Global Pneumonia Vaccine Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Surge in prevalence of pneumonia across the globe
- Rise in government focus on immunization programs for pneumonia
- Increase in focus for novel pneumococcal vaccines
- Restraints
- Longer timelines required for pneumonia vaccine production
- High cost associated with development of such vaccines
- Opportunities
- Development of protein-based combination pneumococcal vaccines
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Pneumonia Vaccine Market, By Vaccine Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Pneumococcal Conjugate Vaccine (PCV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pneumococcal Polysaccharide Vaccine (PPSV/PPV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pneumococcal Conjugate Vaccine (PCV)
- Global Pneumonia Vaccine Market, By Product Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Prevnar 13
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Synflorix
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pneumovax23
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pipeline Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Prevnar 13
- Global Pneumonia Vaccine Market, By Sector, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Public Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Private Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Public Sector
- Global Pneumonia Vaccine Market, By Distribution Channel, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Distribution Partner Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Non-Governmental Organizations (NGO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Government Authorities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Distribution Partner Companies
- Global Pneumonia Vaccine Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Sector, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Pneumonia Vaccine Market, By Vaccine Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Glaxosmithkline Plc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Lg Chem Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck & Co., Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Panacea Biotec Limited
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pfizer Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pnuvax Incorporated
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Serum Institute Of India Pvt. Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Shenzhen Kangtai Biological Products Co., Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Sk Bioscience
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Walvax Biotechnology Co., Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Glaxosmithkline Plc.
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Point-of-Care (POC) Infectious Disease Diagnostics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Polycystic Ovarian Syndrome Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global PoC Platform & Technology Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Pocket Otoscope Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%